MagPAD Medical

MagPAD Medical is a private cardiovascular medtech company developing a magnetic catheter-based access system intended to enable minimally invasive heart procedures. Its core technology, Magnetic Puncture Access and Delivery (MagPAD), uses paired magnet-enabled catheters to create controlled venous-to-arterial access and support large-bore delivery for structural heart interventions. The company positions the device as a way to simplify transcaval access and expand eligibility for transcatheter aortic valve replacement and related procedures in patients who are poor candidates for standard arterial access. MagPAD Medical appears to be an early-stage, preclinical company based in Poughkeepsie, New York, with participation in the 2020 MedTech Innovator accelerator and at least one issued U.S. patent covering its system.